EN

The article “BPatG – Telmisartan. Zur Nichtigkeit von ergänzenden Schutzzertifikaten für Wirkstoffkombinationen” by Ulrike Herr was published in IP kompakt

This article discusses the recent decision “Telmisartan” of the German Federal Patent Court. As a result of this decision a second SPC for a combination of telmisartan and hydrochlorothiazide was declared invalid in view of the decision Actavis (C-443/12) of the European Court of Justice although the corresponding basic patent has been limited. Furthermore, the German Federal Patent Court has clarified that in principal, the basic patent may be limited in view of a nullity suit and that the national limitation retroacts to the date before the date of the SPC request.

Source: IP kompakt No. 9, 2014, Bundesanzeiger Publisher, Cologne

Weitere Beiträge von Dr. Ulrike Herr

SPCs for combination products – The CJEU sets out the criteria for combinations of active ingredients being “protected by a basic patent”

Dr. Ulrike Herr

We are pleased to announce that our Munich partner Dr. Ulrike Herr was reelected today as a member of the Board of the German Chamber of Patent Attorneys

Dr. Ulrike Herr

Preliminary Injunctions rejected in Infringement Proceedings concerning Gilead’s SPC Supplementary Protection Certificate of the anti-HIV drug Truvada in Germany

Dr. Ulrike Herr

Highly Topical: Supplementary Protection Certificates SPCs in Europe – Seattle Genetics Decision (C-471/14) of the CJEU of October 6, 2015 – Good news for SPC Owners

Dr. Ulrike Herr

Urgent Notice of the Federal Patent Court: Preliminary Injunction issued in a Compulsory License Proceedings concerning “Isentress” (raltegravir against AIDS)

Dr. Ulrike Herr

SPCs and Medical Devices: Regulation 469/2009 requires a pharmacological, immunological or metabolic action of the product of its own: BPatG Decision 14 W (pat) 45/12

Dr. Ulrike Herr

Highly Topical: SPCs Supplementary Protection Certificates in Europe – Seattle Genetics Decision (C-471/14) of the CJEU of October 6, 2015 – Good news for SPC Owners

Dr. Ulrike Herr

Reference to an ISO Standard Renders a Claim Unclear under the EPC

Dr. Ulrike Herr

The article “BPatG – Telmisartan. Zur Nichtigkeit von ergänzenden Schutzzertifikaten für Wirkstoffkombinationen” by Ulrike Herr was published in IP kompakt

Dr. Ulrike Herr

Supplementary Protection Certificates – Three post-Medeva Decisions of the CJEU of Dec 12, 2013

Dr. Ulrike Herr

SPC Case Law - Astrazeneca AB/Comptroller-General of Patents C-617/12 of Nov. 14, 2013 (Reasoned order)

Dr. Ulrike Herr